A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
Condition(s):Myasthenia Gravis, GeneralizedLast Updated:March 5, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Myasthenia Gravis, GeneralizedLast Updated:March 5, 2019Completed
Condition(s):Myasthenia GravisLast Updated:January 8, 2021Completed
Condition(s):Myasthenia GravisLast Updated:October 13, 2017Completed
Condition(s):Myasthenia GravisLast Updated:January 26, 2024Not yet recruiting
Condition(s):Refractory Myasthenia GravisLast Updated:January 16, 2013Completed
Condition(s):Generalized Myasthenia GravisLast Updated:March 13, 2020Unknown status
Condition(s):Myasthenia GravisLast Updated:March 30, 2020Completed
Condition(s):Generalized Myasthenia GravisLast Updated:March 27, 2024Active, not recruiting
Condition(s):Generalized Myasthenia Gravis; gMGLast Updated:March 26, 2024Recruiting
Condition(s):Myasthenia Gravis; ThymomaLast Updated:July 10, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.